Detalhe da pesquisa
1.
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
Cell
; 184(5): 1188-1200.e19, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577765
2.
Molecular Architecture of the SARS-CoV-2 Virus.
Cell
; 183(3): 730-738.e13, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32979942
3.
Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4+ T cell recognition.
Nat Immunol
; 23(12): 1726-1734, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456735
4.
Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors.
Immunity
; 55(11): 2149-2167.e9, 2022 11 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36179689
5.
Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and G.
Cell
; 165(4): 813-26, 2016 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27114034
6.
Immunogenicity of Stabilized HIV-1 Envelope Trimers with Reduced Exposure of Non-neutralizing Epitopes.
Cell
; 163(7): 1702-15, 2015 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26687358
7.
Vaccination with Glycan-Modified HIV NFL Envelope Trimer-Liposomes Elicits Broadly Neutralizing Antibodies to Multiple Sites of Vulnerability.
Immunity
; 51(5): 915-929.e7, 2019 11 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31732167
8.
The IgG-specific endoglycosidases EndoS and EndoS2 are distinguished by conformation and antibody recognition.
J Biol Chem
; 300(5): 107245, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569940
9.
Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein.
PLoS Pathog
; 19(8): e1011452, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549185
10.
Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization.
PLoS Pathog
; 19(10): e1011601, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903160
11.
The Glycan Hole Area of HIV-1 Envelope Trimers Contributes Prominently to the Induction of Autologous Neutralization.
J Virol
; 96(1): e0155221, 2022 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34669426
12.
A cross-neutralizing antibody between HIV-1 and influenza virus.
PLoS Pathog
; 17(3): e1009407, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750987
13.
Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens.
PLoS Pathog
; 17(10): e1009807, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34679128
14.
Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.
Blood
; 138(17): 1570-1582, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424958
15.
Structural and functional evaluation of de novo-designed, two-component nanoparticle carriers for HIV Env trimer immunogens.
PLoS Pathog
; 16(8): e1008665, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780770
16.
Augmenting glycosylation-directed folding pathways enhances the fidelity of HIV Env immunogen production in plants.
Biotechnol Bioeng
; 119(10): 2919-2937, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781691
17.
Site-Specific Steric Control of SARS-CoV-2 Spike Glycosylation.
Biochemistry
; 60(27): 2153-2169, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34213308
18.
Development of a high-sensitivity ELISA detecting IgG, IgA and IgM antibodies to the SARS-CoV-2 spike glycoprotein in serum and saliva.
Immunology
; 164(1): 135-147, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33932228
19.
Suppression of O-Linked Glycosylation of the SARS-CoV-2 Spike by Quaternary Structural Restraints.
Anal Chem
; 93(43): 14392-14400, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34670086
20.
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
J Virol
; 94(24)2020 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32999024